Device type · NAW
Microspheres Radionuclide
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NAW
Radiology
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
33
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Microspheres Radionuclide
- Product code
- NAW
- Device class
- Class III
- Review panel
- Radiology
- Specialty
- Radiology & Imaging
- FDA record
- Classification database entry for NAW
Latest FDA decisions
- TheraSpherePMA supplement
P200029-S011 · Decided Feb 10, 2026 · 508 days after receipt · Panel Track
Device type: Microspheres radionuclide (NAW) · Radiology & Imaging
- SIR-Spheres Y-90 resin microspheresPMA supplement
P990065-S014 · Decided Jul 1, 2025 · 532 days after receipt · Panel Track
Device type: Microspheres radionuclide (NAW) · Radiology & Imaging
- TheraSpherePMA
P200029 · Decided Mar 17, 2021 · 266 days after receipt
Device type: Microspheres radionuclide (NAW) · Radiology & Imaging
Reports received
33
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
10
30% of reports
Injury reports
21
64% of reports
Death reports
2
6.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 4 | 0 | 0 |
| Jan 24 | 1 | 2 | 0 | 0 |
| Feb 24 | 1 | 1 | 0 | 0 |
| Mar 24 | 1 | 1 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 3 | 3 | 0 |
| Jul 24 | 0 | 3 | 1 | 0 |
| Aug 24 | 0 | 5 | 0 | 0 |
| Sep 24 | 0 | 3 | 2 | 0 |
| Oct 24 | 0 | 15 | 0 | 0 |
| Nov 24 | 2 | 5 | 0 | 0 |
| Dec 24 | 0 | 1 | 1 | 0 |
| Jan 25 | 0 | 8 | 0 | 0 |
| Feb 25 | 0 | 7 | 0 | 0 |
| Mar 25 | 0 | 18 | 1 | 0 |
| Apr 25 | 0 | 8 | 0 | 0 |
| May 25 | 0 | 4 | 0 | 0 |
| Jun 25 | 0 | 5 | 0 | 0 |
| Jul 25 | 0 | 3 | 0 | 0 |
| Aug 25 | 3 | 11 | 0 | 0 |
| Sep 25 | 0 | 2 | 0 | 0 |
| Oct 25 | 0 | 1 | 0 | 0 |
| Nov 25 | 0 | 3 | 0 | 0 |
| Dec 25 | 1 | 2 | 0 | 0 |
| Jan 26 | 0 | 1 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 1 | 1 | 0 | 0 |
| Apr 26 | 0 | 3 | 1 | 0 |
| May 26 | 0 | 3 | 0 | 0 |
| Jun 26 | 2 | 2 | 1 | 0 |
| Jul 26 | 1 | 1 | 0 | 0 |
| Aug 26 | 2 | 1 | 0 | 0 |
| Sep 26 | 0 | 2 | 0 | 0 |
| Oct 26 | 3 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
3 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem20
- Connection Problem3
- Fluid/Blood Leak3
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions11
- Nausea6
- Unintended Radiation Exposure6
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- TheraSphere Administration Set, REF OTT-SPE-FP-226 (990226.SPE)Open, Classified
Z-2327-2021 · Started Jul 23, 2021 · Posted by FDA Aug 19, 2021
Reason given: Potential for leaks and loosening at the patient catheter connection
Cause as FDA categorized it: Component change control
- TheraSphere Administration Set, REF OTT-SPE-FP-001 (990264.SPE)Open, Classified
Z-2328-2021 · Started Jul 23, 2021 · Posted by FDA Aug 19, 2021
Reason given: Potential for leaks and loosening at the patient catheter connection
Cause as FDA categorized it: Component change control
Z-0078-2017 · Started Sep 21, 2015
Reason given: One mislabeled dose of TheraSphere Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.
Cause as FDA categorized it: Packaging
2 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.